We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current KALA market cap is 38.63M. The company's latest EPS is USD -9.1535 and P/E is -0.89.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.76M | -9.62M | -11.93M | -9.61M | -9.99M |
| Net Income | -8.7M | -8.63M | -11.81M | -9.58M | -8.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.07M | 6.36M | 17.05M | 4.18M | 230k |
| Operating Income | -88.22M | -96.23M | -130.25M | -81.71M | -39.66M |
| Net Income | -94.35M | -104.33M | -142.61M | -44.82M | -42.2M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 61.12M | 55.95M | 53.03M | 61.61M | 54.08M |
| Total Liabilities | 49.9M | 48.45M | 46.37M | 47.89M | 47.22M |
| Total Equity | 11.22M | 7.5M | 6.66M | 13.72M | 6.86M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 154.32M | 221.61M | 139.43M | 86.82M | 55.95M |
| Total Liabilities | 124.63M | 121.61M | 122.62M | 67.85M | 48.45M |
| Total Equity | 29.69M | 100M | 16.8M | 18.97M | 7.5M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.23M | -27.93M | -10.84M | -20.06M | -24.78M |
| Investing | -422k | -429k | -13k | -49k | -139k |
| Financing | 5.97M | 8.51M | 8.44M | 23.41M | 23.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -92.72M | -90.69M | -108.24M | -78.91M | -27.93M |
| Investing | -1.34M | -78.21M | 70.8M | 62.72M | -429k |
| Financing | 8.98M | 160.63M | 42.55M | -7.94M | 8.51M |
| Market Cap | 38.63M |
| Price to Earnings Ratio | -0.89 |
| Price to Sales Ratio | 163.53 |
| Price to Cash Ratio | 0.74 |
| Price to Book Ratio | 5.01 |
| Dividend Yield | - |
| Shares Outstanding | 4.61M |
| Average Volume (1 week) | 199.24k |
| Average Volume (1 Month) | 110.24k |
| 52 Week Change | 16.71% |
| 52 Week High | 11.20 |
| 52 Week Low | 4.21 |
| Spread (Intraday) | 0.41 (4.82%) |
| Company Name | KALA BIO Inc |
| Address |
corporation trust center watertown, massachusetts 19801 |
| Website | https://www.kalarx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
